🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fei Yang

Roche (Switzerland)

ORCID: 0000-0001-8762-8033
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.4Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3
Top 8%
2.7DataRank
Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 12 papers — median percentile 81. Top paper: “Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment”.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3
Top 8%
2.7DataRank
Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0144
N/A
2.0DataRank · unranked
79 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

Breast Cancer Research(2021)10.1186/s13058-021-01406-x
N/A
1.8DataRank · unranked
70 citations

Ming Zhao, Erkan Yuca, Allen Annis, Kurt W. Evans, David Sutton +13 more

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial

Investigational New Drugs(2021)10.1007/s10637-020-01043-9
N/A
1.1DataRank · unranked
25 citations

Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Lois M. Ramondetta, Mingxuan Xu +8 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014
Top 31%
0.652DataRank
Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

npj Breast Cancer(2023)10.1038/s41523-023-00573-8
N/A
0.524DataRank · unranked
32 citations

Timothy P. DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W. Evans +8 more

Large Language Models for Accessible Reporting of Bioinformatics Analyses in Interdisciplinary Contexts

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.09.687479
N/A
0DataRank · unranked
0 citations

Daniel Kim, Yue Cao, Matthew Wei Shun Shu, Maya Shen, Xiaoqi Liang +9 more

Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers

npj Breast Cancer(2022)10.1038/s41523-022-00427-9
N/A
0DataRank · unranked
11 citations

Zhongqi Ge, Fei Yang, Alejandro Contreras, Sanghoon Lee, Jason B. White +9 more

Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer

Scientific Reports(2022)10.1038/s41598-022-22417-4
N/A
0DataRank · unranked
4 citations

Nanyue Chen, Seetharaman Balasenthil, Eugene Lurie, Fei Yang, Suyu Liu +8 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597
N/A
0DataRank · unranked
0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597.v1
N/A
0DataRank · unranked
0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Ovarian GLI1 fusion tumors mimicking sex cord-stromal Tumors: Clinicopathological and molecular characterization of a five-case series

Human Pathology(2025)10.1016/j.humpath.2025.106003
N/A
0DataRank · unranked
1 citations

Yan Liu, Yuxiang Wang, Jing Yang, Lingchao Liu, Congrong Liu +1 more